0

Nifedipine - CAS 21829-25-4

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP21829254-A
CAS21829-25-4
Structure
Molecular Weight346.33
DescriptionRelatively selective blocker of L-type Ca2+ channels.
SolubilityDMSO: soluble; ethanol: soluble
Assay≥98% (UV)
Coloryellow
Formsolid; protect from light
Size250MG
Storage Conditions+15C to +30C
1

Antihypertensive Efficacy of a Slow Release Nifedipine Tablet Formulation Given Once Daily in Patients With Mild to Moderate Hypertension. A Placebo-Controlled, Double-Blind Parallel-Group Trial

S Harder, S Rietbrock, P Thürmann

Arzneimittelforschung. 1994 Feb;44(2):133-6.

PMID: 8147945

1

Effect of Slow Release Nifedipine Tablets in Patients With Essential Hypertension

Y Imai, K Abe, M Munakata, S Sasaki, N Minami, H Sakuma, J Hashimoto, N Watanabe, M Sakuma, H Sekino

Arzneimittelforschung. 1992 Dec;42(12):1434-8.

PMID: 1288507

1

Evaluation of the Inhibitory Effect of Dihydropyridines on N-type Calcium Channel by Virtual Three-Dimensional Pharmacophore Modeling

Takuo Ogihara, Takashi Kano, Chihaya Kakinuma

Arzneimittelforschung. 2009;59(6):283-8.

PMID: 19634509

1

Interaction Potential of Lercanidipine, a New Vasoselective Dihydropyridine Calcium Antagonist

Ulrich Klotz

Arzneimittelforschung. 2002;52(3):155-61.

PMID: 11963641

1

Synthesis and Calcium Channel Antagonist Activity of 1,4-dihydropyridine Derivatives Containing 4-nitroimidazolyl Substituents

Abbas Shafiee, Noushin Rastkary, Masoumeh Jorjani

Arzneimittelforschung. 2002;52(7):537-42.

PMID: 12189777

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode